Home › Ductal Carcinoma In Situ (DCIS) › Illinois
Ductal Carcinoma In Situ (DCIS) clinical trials in Illinois
5 studies for Ductal Carcinoma In Situ (DCIS) are looking for participants at sites in Illinois.
Cities in Illinois
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- University of Chicago Medical Center, Chicago
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT06075953Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- University of Chicago, Chicago
RecruitingHealthy volunteers welcome
Ages 30 to 74 · Women · Updated Sep 21, 2026 · NCT02620852Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- Northwestern University, Chicago
- University of Illinois College of Medicine - Chicago, Chicago
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Northwestern University, Chicago
RecruitingPhase 2
Ages 35 and older · Women · Updated Jul 7, 2026 · NCT05941520The PREDICT Registry:
- Endeavor Health (Northshore), Evanston
RecruitingObservational study
Ages 30 to 85 · Women · Updated Apr 17, 2026 · NCT03448926From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.